NEW Extended Dwell Time for Expanded Versatility

The expanded indications for use for the Arrow® EZ-IO® Intraosseous Vascular Access System have been cleared by the U.S. Food and Drug Administration. 


The EZ-IO® System is indicated for intraosseous access anytime in which vascular access is difficult to obtain in emergent, urgent or medically necessary cases for up to 24 hours. 


Now, for patients ≥ 12 years old, use of the device may be extended for up to 48 hours when alternate intravenous access is not available or reliably established.


Only the Arrow® EZ-IO® System gives you this extended dwell time 

A few commonly asked questions

Q: Does the syringe flush have to be repeated with prolonged use?

A: IO access may be compromised if the line is not used for prolonged periods. Often, IO lines can be opened by an additional syringe flush. In a clinical volunteer study, an infusion rate of 30ml/hour per infusion pump has been sufficient to maintain IO line patency for a period of 48 hours.1

Q: Is there more or less pain as the IO is left in longer?

A: Pain associated with IO infusion is subjective and varies among patients. Site selection, repeat saline flushes, and flow rates can affect pain. The proximal humerus site should be strongly considered for higher flow rates and ease of pain control as fluids tend to flow easier through the humerus, requiring less pressure to deliver the
initial flush.2-4


Q: Is the Arrow® EZ-Stabilizer® Dressing indicated to be left in place for 48 hours?

A: Yes, the EZ-Stabilizer® Dressing was evaluated and qualified for a 48-hour placement on the skin as part of the EZ-IO® Intraosseous Vascular Access System.   

Questions?

Have your rep contact you:

Customer Support
Teleflex 3015 Carrington Mill Boulevard, Morrisville, NC 27560
Toll Free: 866-246-6990 Phone: 919-544-8000 | Fax: 866-804-9881 | Email: Customer Service

By completing this form, you are granting Teleflex permission to add your contact information to its database and consent to receiving product and educational information and communications related to Teleflex products and services. You may revoke this permission at any time by emailing EMS@teleflex.com. Teleflex respects the confidentiality of personal information. We will not share your personal information, except as otherwise noted in our privacy policy on our website.


References:
1. Data on File. Teleflex Incorporated. 2016
2. Philbeck, T. E., Miller, L. J., Montez, D., & Puga, T. (2010). Hurts so good. Easing IO pain and pressure. JEMS  35(9), 58-62.
3. Sawyer RW, Bodai BI, Blaissel FW et al. The current status of intraosseous infusion. J Am Coll Surg. 1994; 179:353-360.
4. Warren DW, Kissoon N, Sommerauer J, et al. Comparison of fluid infusion rates among peripheral intravenous and humerus, femur, malleolus, and tibial intraosseous sites in normovolemic and hypovolemic piglets. Ann Emerg Med. 1993; 22:183-186.

Rx Only.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.
The Arrow® EZ-IO® Needle Set is Sterile, Single Use: Do not reuse, reprocess or re-sterilize. Reuse of device creates a potential risk of serious injury and/or infection which may lead to death. Refer to Instructions for Use for complete warnings, indications, contraindications, precautions, and potential complications.

Teleflex, the Teleflex logo, Arrow, EZ-IO, and EZ-Stabilizer are trademarks or registered trademarks of Teleflex and its affiliates, in the U.S. and/or other countries. All rights reserved. ©2020 Teleflex Incorporated. MC-006542